Potential of differentiated iPS cells in cell therapy without immune rejection

The study, published online in Cell Stem Cell , demonstrates the potential of utilizing iPS cells to develop cell types that could offer treatment for a wide range of conditions, including diabetes, liver and lung diseases, without the barrier of immune rejection.

http://www.sciencedaily.com/releases/2013/01/130125154813.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fmost_popular+%28ScienceDaily%3A+Most+Popular+News%29